Bio Pharma Dive
APRIL 19, 2021
If approved, TG's drug would join Roche's fast-selling Ocrevus and Novartis' newer entrant Kesimpta as one of a newer class of multiple sclerosis therapies.
World of DTC Marketing
APRIL 21, 2021
QUICK READ: There is so much money in healthcare that every company wants their share even if patients get hurt. The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value. It’s going to continue until we put politics aside and say “enough.” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharma company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
APRIL 22, 2021
The same group at the University of Oxford and the Jenner Institute that developed the AstraZeneca-Oxford COVID-19 vaccine reported that their investigational malaria vaccine, R21/Matrix-M, demonstrated 77% efficacy in children over 12 months of follow-up.
pharmaphorum
APRIL 19, 2021
The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . Last August the UK government finalised a deal with Novavax to purchase 60 million doses of the NVX-CoV2373 vaccine, which will also be manufactured in the country at a plant owned by FUJIFILM Diosynth Biotechnologies in Stockton-on-Tees.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
APRIL 20, 2021
New developments could come soon for two coronavirus vaccines while, a bit further off, the fate of Biogen's Alzheimer's drug hangs in the balance. Important data are expected, too, for Vertex and Sarepta.
World of DTC Marketing
APRIL 22, 2021
QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s side effects and cost. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Camargo
APRIL 20, 2021
Cancer is not a single disease, but rather hundreds of different diseases. Thus, there will never be a single cure to cancer. As our knowledge of oncology science advances and expands, a growing number of malignancy types and subtypes are constantly being identified, breaking down target patient populations into ever-smaller fractions. This trend progressively reduces the attractiveness of engaging in the early stages of oncology therapy development in the eyes of Big Pharma and opens the space
Bio Pharma Dive
APRIL 19, 2021
Adagio Therapeutics, a well-financed spinout of antibody developer Adimab, could challenge Regeneron and Eli Lilly if its drug candidate proves protective in clinical tests.
World of DTC Marketing
APRIL 20, 2021
QUICK READ: Here are some recent stories that you should all be aware of. Last month I hit 80,000 readers when accounting for email, social media, and direct traffic. I love the industry, and although I want to see some changes, I know there are many good people trying every day to make it happen. After a year of pandemic-delayed medical tr eatments, doctors are seeing more cases of advanced illnesses.
pharmaphorum
APRIL 23, 2021
Two years ago the use of AI in pharma and healthcare looked to be quickly heading for what Gartner’s Hype Cycle model would term the Plateau of Productivity. After the COVID-powered digital transformations of both pharma and healthcare , there can be little doubt that artificial intelligence is already having a productive time across our sector. It could even be, as consultants GlobalData predicted back in January, this year’s most disruptive technology across the pharmaceutical industry, though
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
APRIL 22, 2021
Study will include approximately 1,000 people with obesity or overweight with comorbidities
Bio Pharma Dive
APRIL 23, 2021
A vaccine co-developed by the U.K. academic center and the Maryland biotech could be the first to meet the WHO's efficacy target for a malaria vaccine.
World of DTC Marketing
APRIL 19, 2021
QUICK READ: At times, the public health response to coronavirus (COVID-19) has been scary, characterized by antimask behavior, antivaccine beliefs, conspiracy theories around the development of the vaccine, and a general belief that even COVID numbers are false. These people are doing more harm to others than they know, and they are generally making themselves irrelevant.
BioSpace
APRIL 22, 2021
Executives at pharmaceutical companies are known for receiving large salaries. When bonuses and stock options are factored into the picture, their annual compensation can jump into the range of tens of millions of dollars, like Pfizer’s Albert Bourla, Alex Gorsky from Johnson & Johnson, and Astra.
Pharma Times
APRIL 20, 2021
Decision is based on results from the Phase II DESTINY-Breast01 trial
Bio Pharma Dive
APRIL 23, 2021
While health officials have documented more cases of a rare blood clotting syndrome associated with J&J's vaccine, a CDC committee supported use of the shot with an added warning.
World of DTC Marketing
APRIL 23, 2021
QUICK READ: The MedAd News Manny Awards were last night. Congratulations to the winners, but the bar has been set higher if pharma is to really demonstrate they care about patients. Award winners should see their awards as a head nod and understand they have a LOT more work to do. I’m not much for pharma trade magazine awards. Too much self-promotional politics in involved but still it’s great to be recognized.
XTalks
APRIL 19, 2021
In 2018 , Coke tested their Coca-Cola Stevia No Sugar product in New Zealand to see how this beverage would succeed in the market before launching it in other countries. But where is the beverage now? Is Coke Stevia Still Available? Coke with stevia was distributed worldwide until it slowly started losing sales and has now been discontinued and removed from The Coca-Cola Company’s product portfolio.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
APRIL 20, 2021
Pharma and diagnostic sectors respond to organisation’s latest guideline recommendations
Bio Pharma Dive
APRIL 21, 2021
Two Phase 3 trials have now shown that Lilly's autoimmune drug baricitinib may effectively treat alopecia areata. But the FDA's concerns with so-called JAK inhibitors could complicate a review.
Outsourcing Pharma
APRIL 19, 2021
One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.
Scienmag
APRIL 19, 2021
Credit: James Herndon A new type of collective behaviour in ants has been revealed by an international team of scientists, headed by biologist Professor Iain Couzin, co-director of the Cluster of Excellence “Centre for the Advanced Study of Collective Behaviour” at the University of Konstanz and director at the co-located Max Planck Institute of Animal […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Times
APRIL 23, 2021
Construction on Leiden, Netherlands site anticipated to begin later this year
Bio Pharma Dive
APRIL 22, 2021
Six accelerated approvals for immunotherapies from Merck, Bristol Myers Squibb and Roche might soon be withdrawn. Here's a detailed look at why.
XTalks
APRIL 23, 2021
GSK’s immunotherapy dostarlimab-gxly (Jemperli) has been granted accelerated approval by the US Food and Drug Administration (FDA) for the treatment of recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer. The therapy is indicated for endometrial cancer that has progressed during, or following, prior treatment with a platinum-based chemotherapy, and in women with dMMR tumors as determined by an FDA-approved test. dMMR occurs when a cell is unable to repair errors made during
BioPharma Reporter
APRIL 22, 2021
Israel has set up COVID-19 vaccine orders with Pfizer and Moderna this week: marking deals over the longer term for the two companies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
APRIL 20, 2021
Data comes from 3.
Bio Pharma Dive
APRIL 20, 2021
The biotech will cut staff, primarily in Europe, after negotiations with German health authorities resulted in a price lower than Bluebird had sought.
XTalks
APRIL 22, 2021
Today is Earth Day and this year’s theme is Restore Our Earth. “At the heart of Earth Day’s 2021 theme, Restore Our Earth, is optimism, a critically needed sentiment in a world ravaged by both climate change and the pandemic,” said Kathleen Rogers, president of EarthDay.org, in a press release. This theme comes at a time when COVID-19 has claimed the lives of over three million people around the world and the effects of climate changes have manifested in the form of ragin
pharmaphorum
APRIL 19, 2021
French genomic medicines firm SparingVision has agreed to buy GAMUT Therapeutics, a biotech specialising in gene therapies for inherited eye diseases such as retinitis pigmentosa (RP) that could compete against Roche/Spark’s Luxturna in a wider patient group. . GAMUT’s lead product, now SPVN20, is a novel, mutation-agnostic gene therapy, which aims at restoring the function of dormant cone cells in the retina.
Expert insights. Personalized for you.
363 
Let's personalize your content